Welcome to the world
of Théa Open Innovation
Théa Open Innovation aims to identify, assess and set up partnerships between start-ups universities and research teams’best innovative solutions to help develop new treatments for eyes diseases.
Latest news
Sepul Bio, an innovative business unit of Théa, Doses First Participant in Phase 3 HYPERIONclinical trial of sepofarsen for CEP290-associated Leber Congenital Amaurosis Type 10
Clermont-Ferrand, France, Wednesday 1 October 2025 – Sepul Bio, an
Théa and Kiora Pharmaceuticals sign a new partnership
Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement
Théa and Link Biologics sign a new partnership
Théa and Link Biologics sign a new partnership
The Théa Open Innovation Team

Mélissa CHERVY,
Scientific Assessement Officer

Marjorie BARDIN,
Executive Assistant

Jocelyn MARTIN,
Alliance Manager

Marie DAVAL,
Alliance Manager

Simon BORION,
Market Business Analyst

Eric BARBAN,
Head of Business Assessment

Antoine JOYAUX,
Business Development Manager

Stéphane THUMELIN,
Head of Business Development

Samir PATEL,
Early-stage Medical Director

Fabrice MERCIER,
Medical Technology Director

Laure PENIN-PEYTA,
Scientific Assessment Manager

Céline OLMIERE,
Head of Théa Open Innovation